$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Rasagiline (Anqilai) original manufacturer information and drug source description
2026-02-01 22:25:32
Check Details
Regular purchasing channels and precautions for generic drugs of Pralsetinib
2026-02-01 22:25:32
Check Details
How to handle capmatinib (Touradida) correctly after missing a dose
2026-02-01 22:25:32
Check Details
Is sotoracib (AMG 510) combined with PD-1 immunotherapy more effective?
2026-02-01 22:25:32
Check Details
Whether adagrasib (Krazati) can be vaccinated and what precautions should be taken during vaccination
2026-02-01 22:25:32
Check Details
Interpretation of the efficacy and price of the cancer targeted drug Lorlatinib: the medication and purchasing guide that patients are most concerned about
2026-02-01 22:25:32
Check Details
Related introduction of Dawnzera (donidalorsen): What kind of medicine is it used to treat?
2026-02-01 22:25:32
Check Details
Enzalutamide combined with leuprolide produces OS benefit in patients with non-Hodgkin lymphoma with biochemical recurrence
2026-02-01 22:25:32
Check Details
What are the main targets of Sorafenib/Nexavar and how do they work?
2026-02-01 22:25:32
Check Details
Is pemetinib/pemetinib included in the national medical insurance?
2026-02-01 22:25:32
Check Details
Full text analysis of Erdafitinib/Bocco drug instructions
2026-02-01 22:25:32
Check Details
Dacomitinib/Dozerun can be taken for a maximum of several years
2026-02-01 22:25:32
Check Details
1
2
...
2030
2031
2032
2033
2034
2035
2036
...
10240
10241
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ponatinib in the PACE Phase II Trial: Response Data in Resistant CML and Ph+ ALL
2
Selumetinib for NF1-Related Plexiform Neurofibromas: Time to Response and Response Assessment
3
How to Take Tucatinib (Tukysa): Dosing Schedule, Combination Use & Missed Dose Guidance
4
Ganaxolone Common Side Effects: Somnolence, Sedation and Safety Notes
5
Baxdrostat: Efficacy and Safety of a Novel Aldosterone Synthase Inhibitor
6
Anamorelin (ADLUMIZ): GHS-R1a Agonist for Cancer Cachexia—Mechanism, Use, and Safety Boundaries
7
Vemurafenib Mechanism and Clinical Indications: BRAF V600E Mutant Melanoma and ECD Treatment
8
Anagrelide Cautions and Contraindications: Allergy, Hepatic, Cardiac and Bleeding Risks
9
FDA Accelerated Approval of Voceryq: First Plasmid DNA Immunotherapy for Adult Recurrent Respiratory Papillomatosis
10
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
11
Revumenib: Key Considerations Before and During Treatment
12
Pacritinib in Myelofibrosis: Evidence on Spleen Volume Reduction and Symptom Control